EUVIMEDEUVIMED entdecken
Crossref

Drugs for Atopic Dermatitis

The Medical Letter on Drugs and Therapeutics · 02.03.2026 · 68 (1749) · 33-40

DOI: 10.58347/tml.2026.1749a ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Medical Letter on Drugs and Therapeutics, online erschienen am 02.03.2026.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD), also known as eczema, is frequently associated with other atopic disorders such as allergic rhinitis, asthma, and food allergy. It commonly presents in infancy and early childhood and has a relapsing course, often improving by adolescence, but sometimes persisting into or first appearing in adulthood or even old age.1 Guidelines for the treatment of AD have recently been updated.

Schlagwörter

Stichwörter der Autor:innen

AdbryAnzupgoApexiConAzasanCellceptCibinqoClobexDesonideEbglyssEucrisaGengrafImuranNemluvioNeoralOlumiant

Zitieren

APA

(2026). Drugs for Atopic Dermatitis. The Medical Letter on Drugs and Therapeutics, 68(1749), 33-40. https://doi.org/10.58347/tml.2026.1749a

Vancouver

Drugs for Atopic Dermatitis. The Medical Letter on Drugs and Therapeutics. 2026;68(1749):33-40. doi:10.58347/tml.2026.1749a

BibTeX
@article{euvimed2026,
  title = {Drugs for Atopic Dermatitis},
  journal = {The Medical Letter on Drugs and Therapeutics},
  year = {2026},
  volume = {68},
  number = {1749},
  pages = {33--40},
  doi = {10.58347/tml.2026.1749a}
}
Kostenlos starten →